Clinical Trial Update: Modulus in XLIF Study

View source ↗

Summary

NuVasive's Modulus XLIF trial has completed, evaluating outcomes for degenerative disc disease, degenerative spondylolisthesis, and degenerative scoliosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Degenerative Scoliosis
• Degenerative Spondylolisthesis

Drugs mentioned

• Modulus

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis | Status: COMPLETED